Abnormalities in white matter microstructure associated with chronic ketamine use

Neuropsychopharmacology

Volumn 39, Issue 2, 2014, Pages 329-338

  Edward Roberts, R ^a   Curran, H Valerie ^a   Friston, Karl J ^a   Morgan, Celia J A ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

addiction; connectivity; glutamate; ketamine; schizophrenia; white matter

Indexed keywords

KETAMINE;

ADULT; ARTICLE; BRAIN CORTEX; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; DISSOCIATIVE DISORDER; DRUG USE; FEMALE; HUMAN; MALE; PREDICTIVE VALIDITY; PREFRONTAL CORTEX; PRIORITY JOURNAL; QUESTIONNAIRE; RIGHT HEMISPHERE; SCHIZOTYPAL PERSONALITY DISORDER; TRACTOGRAPHY; WHITE MATTER;

ADULT; BRAIN CHEMISTRY; CHRONIC DISEASE; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; KETAMINE; MALE; MIDDLE AGED; NERVE FIBERS, MYELINATED; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84890566943     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2013.195     Document Type: Article

References (47)

1. Alexander DANIELC, Seunarine KIRANK (2010). Mathematics of Crossing Fibers. Diffusion MRI: Theory, Methods, and Applications. Oxford University Press: New York, NY, USA, pp 451-464.
2. Baddeley A, Emslie H, Nimmo Smith I (1993). The spot-the-word test: a robust estimate of verbal intelligence based on lexical decision. Br J Clin Psychol 32: 55-65.
3. Basser PJ, Mattiello J, Lebihan D (1994). Estimation of the effective self-diffusion tensor from the Nmr Spin-Echo. J Magn Reson B 103: 247-254.
4. Beaulieu C (2002). The basis of anisotropic water diffusion in the nervous system-a technical review. NMR Biomed 15: 435-455.
5. Behrens TEJ, Johansen-Berg H, Woolrich MW, Smith SM Wheeler-Kingshott CAM, Boulby PA et al (2003). Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. Nat Neurosci 6: 750-757.
6. Bernstein EM, Putnam FW (1986). Development, reliability, and validity of a dissociation scale. J Nerv Ment Dis 174: 727-735.
7. Blakemore S-J, Choudhury S (2006). Development of the adolescent brain: implications for executive function and social cognition. J Child Psychol Psychiatr 47: 296-312.
8. Brozoski TJ, Brown RM, Rosvold HE, Goldman PS (1979). Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 205: 929-932.
9. Corlett PR, Honey GD, Aitken MRF, Dickinson A, Shanks DR Absalom AR et al (2006). Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: linking cognition, brain activity, and psychosis. Arch Gen Psychiatry 63: 611.
10. Corlett PR, Honey GD, Fletcher PC (2007). From prediction error to psychosis: ketamine as a pharmacological model of delusions. J Psychopharmacol 21: 238-252.
11. Dawson N, Morris BJ, Pratt JA (2011). Subanaesthetic ketamine treatment alters prefrontal cortex connectivity with thalamus and ascending subcortical systems. Schizophr Bull 39: 366-377.
12. Deichmann R, Schwarzbauer C, Turner R (2004). Optimisation of the 3D MDEFT sequence for anatomical brain imaging: technical implications at 1.5 and 3T. Neuroimage 21: 757-767.
13. Desikan RS, Ségonne F, Fischl B, Quinn BT, Dickerson BC Blacker D et al (2006). An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31: 968-980.
14. Eickhoff SB, Stephan KE, Mohlberg H, Grefkes C, Fink GR, Amunts K et al (2005). A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. Neuroimage 25: 1325-1335.
15. Ersche KD, Jones PS, Williams GB, Turton AJ, Robbins TW Bullmore ET (2012). Abnormal brain structure implicated in stimulant drug addiction. Science 335: 601-604.
16. Friston KJ, Frith CD (1995). Schizophrenia: a disconnection syndrome. Clin Neurosci 3: 89-97.
17. Goldstein RZ, Volkow ND (2002). Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159: 1642.
18. Honey GD, Corlett PR, Absalom AR, Lee M, Pomarol-Clotet E Murray GK et al (2008). Individual differences in psychotic effects of ketamine are predicted by brain function measured under placebo. J Neurosci 28: 6295-6303.
19. Jansons KM, Alexander DC (2003). Persistent angular structure: new insights from diffusion magnetic resonance imaging data. Inf Process Med Imaging 18: 672-683.
20. Jentsch JD, Roth RH (1999). The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20: 201-225.
21. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R Bremner JD et al (1994). Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51: 199.
22. Laruelle M, Frankle WG, Narendran R, Kegeles LS, Adi-Dargham A (2005). Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation. Clin Ther 27: S16-S24.
23. Liao Y, Tang J, Corlett PR, Wang X, Yang M, Chen H et al (2011). Reduced dorsal prefrontal gray matter after chronic ketamine use'. Biol Psychiatry 69: 42-48.
24. Liao Y, Tang J, Ma M, Wu Z, Yang M, Wang X et al (2010). Frontal white matter abnormalities following chronic ketamine use: a diffusion tensor imaging study. Brain 133: 2115.
25. Lipska BK, Weinberger DR, Swerdlow NR, Geyer MA, Braff DL Jaskiw GE (1995). Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology 122: 35-43.
26. Marenco S, Stein JL, Savostyanova AA, Sambataro F, Tan HY Goldman AL et al (2011). Investigation of anatomical thalamocortical connectivity and fmri activation in schizophrenia. Neuropsychopharmacology 37: 499-507.
27. Mason O, Claridge G, Jackson M (1995). New scales for the assessment of schizotypy. Pers Individ Dif 18: 7-13.
28. Mcdonald JW, Althomsons SP, Hyrc KL, Choi DW, Goldberg MP (1998). Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat Med 4: 291-297.
29. Meyer F, Louilot A (2012). Early prefrontal functional blockade in rats results in schizophrenia-related anomalies in behavior and dopamine. Neuropsychopharmacology 37: 2233-2243.
30. Moghaddam B, Adams B, Verma A, Daly D (1997). Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17: 2921-2927.
31. Morgan CJA, Monaghan L, Curran HV (2004a). Beyond the K-hole: a 3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug. Addiction 99: 1450-1461.
32. Morgan CJA, Mofeez A, Brandner B, Bromley L, Curran HV (2004b). Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers. Neuropsychopharmacology 29: 208-218.
33. Morgan CJA, Muetzelfeldt L, Curran HV (2010). Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study. Addiction 105: 121-133.
34. Mori S, Wakana S, Van Zijl PCM, Nagae-Poetscher LM (2005). MRI Atlas of Human White Matter. Elsevier: Amsterdam, The Netherlands.
35. Narendran R, Frankle WG, Keefe R, Gil R, Martinez D, Slifstein M et al (2005). Altered prefrontal dopaminergic function in chronic recreational ketamine users. Am J Psychiatry 162: 2352-2359.
36. Nichols T. E, Holmes A. P (2002). Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp 15: 1-25.
37. Oouchi H, Yamada K, Sakai K, Kizu O, Kubota T, Ito H et al (2007). Diffusion anisotropy measurement of brain white matter is affected by voxel size: underestimation occurs in areas with crossing fibers. Am J Neuroradiol 28: 1102-1106.
38. Pitt David, Gonzales E, Cross AH, Goldberg MP (2010). Dysmyelinated axons in shiverer mice are highly vulnerable to A-amino-3-hydroxy-5-methylisoxazole- 4-propionic acid (AMPA) receptor-mediated toxicity. Brain Res 1309: 146-154.
39. Reese TG, Heid O, Weisskoff RM, Wedeen VJ (2003). Reduction of Eddy-current-induced distortion in diffusion MRI using a twice-refocused spin echo. Magn Reson Med 49: 177-182.
40. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE Mackay CE et al (2006). Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 31: 1487-1505.
41. Smith S. M (2002). Fast robust automated brain extraction. Hum Brain Mapp 17: 143-155.
42. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TEJ, Johansen-Berg H et al (2004). Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23: 208-219.
43. Song SK, Sun SW, Ju WK, Lin SJ, Cross AH, Neufeld A. H (2003). Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage 20: 1714-1722.
44. Song SK, Yoshino J, Le TQ, Lin SJ, Sun SW, Cross AH et al (2005). Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage 26: 132-140.
45. Verma A, Moghaddam B (1996). NMDA receptor antagonists impair prefrontal cortex function as accessed via spatial delayed alternation performance in rats: modulation by dopamine. J Neurosci 16: 373-379.
46. Wakana S, Caprihan A, Panzenboeck MM, Fallon JH, Perry M Gollub RL et al (2007). Reproducibility of quantitative tractography methods applied to cerebral white matter. Neuroimage 36: 630-644.
47. Wheeler-Kingshott CAM, Hickman SJ, Parker GJM, Ciccarelli O Symms MR, Miller DH et al (2002). Investigating cervical spinal cord structure using axial diffusion tensor imaging. Neuroimage 16: 93-102.